Álvarez-Bustos Alejandro, Carnicero Jose A, Rodríguez-Sánchez Beatriz, El-Assar Mariam, Rueda Ricardo, Pereira Suzette L, Sepúlveda-Loyola Walter, Garcia-Garcia Francisco J, Sulo Suela, Rodríguez-Mañas Leocadio
Centro de Investigación Biomédica en Red sobre Fragilidad y Envejecimiento Saludable (CIBERFES), Instituto de Salud Carlos III, Madrid, Spain.
Fundación de Investigación Biomédica, Hospital Universitario de Getafe, Getafe, Spain.
JACC Adv. 2023 Jul 5;2(5):100423. doi: 10.1016/j.jacadv.2023.100423. eCollection 2023 Jul.
Arterial stiffness leads to several adverse events in the older population, but there is a lack of data on its association with frailty, disability, and mortality in the same population.
The purpose of this study was to evaluate the role of arterial stiffness in the loss of functional ability (frailty and disability) and mortality.
Data were taken from community-dwelling aged 65 years participants without diabetes in the Toledo Study of Healthy Ageing cohort. Pulse wave velocity (PWV), assessed through SphygmoCor, was recorded at baseline. Median follow-up time were 2.99 years for frailty (frailty phenotype [FP] and Frailty Trait Scale-5 [FTS5]) and disability (Katz Index) and 6.2 for mortality. Logistic regressions models were built for disability and frailty and Cox proportional hazards model for death, adjusted by age and sex, comorbidity, cardiovascular risk factors, asymmetric dimethylarginine levels, and polypharmacy.
Overall, 978 (mean age 74.5 ± 5.6 years, 56.7% female) participants were included. Different cut-off points were shown for each outcome. PWV >11.5 m/s was cross-sectionally associated with frailty (FP: OR fully-adjusted model: 1.69, 95% CI: 1.45-1.97; FTS5: OR: 1.51, 95% CI: 1.22-1.87) and disability (OR: 1.51, 95% CI: 1.26-1.79); PWV >10 m/s with incident frailty by FP (OR: 1.36, 95% CI: 1.10-1.68) and FTS5 (OR: 1.40, 95% CI: 1.12-1.75), and PWV >11 m/s with death (HR: 1.28, 95% CI: 1.09-1.50). For incident (OR: 1.28, 95% CI: 1.06-1.55) and worsening disability (OR: 1.21, 95% CI: 1.02-1.45) the threshold was 12.5 m/s. Below these cut-off points, age was the best predictor of adverse outcomes.
Arterial stiffness predicts frailty, disability, and mortality in older people, with different cut-off points, ie,severity degrees, for each of the assessed outcomes.
动脉僵硬度会在老年人群中引发多种不良事件,但缺乏关于其与同一人群中衰弱、残疾和死亡率之间关联的数据。
本研究旨在评估动脉僵硬度在功能能力丧失(衰弱和残疾)及死亡率方面的作用。
数据取自托莱多健康老龄化队列研究中年龄在65岁及以上且无糖尿病的社区居民参与者。通过SphygmoCor评估的脉搏波速度(PWV)在基线时进行记录。衰弱(衰弱表型[FP]和衰弱特质量表-5[FTS5])和残疾(卡茨指数)的中位随访时间为2.99年,死亡率的中位随访时间为6.2年。针对残疾和衰弱建立逻辑回归模型,针对死亡建立Cox比例风险模型,并根据年龄、性别、合并症、心血管危险因素、不对称二甲基精氨酸水平和多重用药情况进行调整。
总体纳入了978名参与者(平均年龄74.5±5.6岁,56.7%为女性)。每个结局都显示了不同的切点。PWV>11.5米/秒与衰弱(FP:完全调整模型的OR:1.69,95%CI:1.45-1.97;FTS5:OR:1.51,95%CI:1.22-1.87)和残疾(OR:1.51,95%CI:1.26-1.79)呈横断面关联;PWV>10米/秒与FP定义的新发衰弱(OR:1.36,95%CI:1.10-1.68)和FTS5定义的新发衰弱(OR:1.40,95%CI:1.12-1.75)相关,PWV>11米/秒与死亡相关(HR:1.28,95%CI:1.09-1.50)。对于新发残疾(OR:1.28,95%CI:1.06-1.55)和残疾恶化(OR:1.21,95%CI:1.02-1.45),阈值为12.5米/秒。低于这些切点时,年龄是不良结局的最佳预测因素。
动脉僵硬度可预测老年人的衰弱、残疾和死亡率,且对于每个评估结局都有不同的切点,即严重程度。